期刊文献+

Roles of histamine and its receptors in allergic and inflammatory bowel diseases 被引量:12

Roles of histamine and its receptors in allergic and inflammatory bowel diseases
暂未订购
导出
摘要 Mast cell has a long history of being recognized as an important mediator-secreting cell in allergic diseases, and has been discovered to be involved in IBD in last two decades. Histamine is a major mediator in allergic diseases, and has multiple effects that are mediated by specific surface receptors on target cells. Four types of histamine receptors have now been recognized pharmacologically and the first three are located in the gut. The ability of histamine receptor antagonists to inhibit mast cell degranulation suggests that they might be developed as a group of mast cell stabilizers. Recently, a series of experiments with dispersed colon mast cells suggested that there should be at least two pathways in man for mast cells to amplify their own activation-degranulation signals in an autocrine or paracrine manner. In a word, histamine is an important mediator in allergic diseases and IBD, its antagonists may be developed as a group of mast cell stabilizers to treat these diseases. Mast cell has a long history of being recognized as an important mediator-secreting cell in allergic diseases, and has been discovered to be involved in IBD in last two decades. Histamine is a major mediator in allergic diseases, and has multiple effects that are mediated by specific surface receptors on target cells. Four types of histamine receptors have now been recognized pharmacologically and the first three are located in the gut. The ability of histamine receptor antagonists to inhibit mast cell degranulation suggests that they might be developed as a group of mast cell stabilizers. Recently, a series of experiments with dispersed colon mast cells suggested that there should be at least two pathways in man for mast cells to amplify their own activation-degranulation signals in an autocrine or paracrine manner. In a word, histamine is an important mediator in allergic diseases and IBD, its antagonists may be developed as a group of mast cell stabilizers to treat these diseases.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第19期2851-2857,共7页 世界胃肠病学杂志(英文版)
基金 Supported by the Li Ka Shing Foundation, Hong Kong, China, No.C0200001 the Planned Science and Technology Project of Guangdong Province, China, No. 2003B31502
关键词 Allergic diseases IMMUNOGLOBULIN 组胺 组胺受体 过敏症 溃疡性肠疾病 病理机制
  • 相关文献

参考文献1

二级参考文献2

共引文献6

同被引文献49

引证文献12

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部